Compared to Estimates, Ametek (AME) Q1 Earnings: A Look at Key Metrics

01.05.25 15:30 Uhr

Werte in diesem Artikel
Aktien

146,38 EUR -0,08 EUR -0,05%

Indizes

1.854,4 PKT -8,4 PKT -0,45%

5.686,7 PKT 82,5 PKT 1,47%

For the quarter ended March 2025, Ametek (AME) reported revenue of $1.73 billion, down 0.2% over the same period last year. EPS came in at $1.75, compared to $1.64 in the year-ago quarter.The reported revenue represents a surprise of -0.51% over the Zacks Consensus Estimate of $1.74 billion. With the consensus EPS estimate being $1.69, the EPS surprise was +3.55%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Ametek performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Electronic Instruments: $1.14 billion versus the five-analyst average estimate of $1.16 billion. The reported number represents a year-over-year change of -1.1%. Net Sales- Electro mechanical: $588.30 million versus $581.78 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +1.5% change. Operating Income- Electronic Instruments: $354.05 million versus the five-analyst average estimate of $347.56 million. Operating Income- Corporate administrative expenses: -$27.94 million compared to the -$26.38 million average estimate based on five analysts. Operating Income- Electromechanical: $128.72 million versus the five-analyst average estimate of $122.95 million. View all Key Company Metrics for Ametek here>>>Shares of Ametek have returned -1.8% over the past month versus the Zacks S&P 500 composite's -0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AMETEK, Inc. (AME): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ametek und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Ametek

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ametek

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ametek Inc.

Wer­bung

Analysen zu Ametek Inc.

DatumRatingAnalyst
04.08.2017Ametek OutperformBMO Capital Markets
08.06.2017Ametek BuyStifel, Nicolaus & Co., Inc.
08.02.2017Ametek OutperformRBC Capital Markets
22.12.2016Ametek OutperformRobert W. Baird & Co. Incorporated
02.11.2016Ametek OutperformRBC Capital Markets
DatumRatingAnalyst
04.08.2017Ametek OutperformBMO Capital Markets
08.06.2017Ametek BuyStifel, Nicolaus & Co., Inc.
08.02.2017Ametek OutperformRBC Capital Markets
22.12.2016Ametek OutperformRobert W. Baird & Co. Incorporated
02.11.2016Ametek OutperformRBC Capital Markets
DatumRatingAnalyst
29.04.2016Ametek NeutralRobert W. Baird & Co. Incorporated
31.10.2012Ametek neutralUBS AG
13.02.2012Ametek neutralUBS AG
31.01.2012Ametek neutralUBS AG
19.09.2011Ametek neutralUBS AG
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ametek Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen